ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Risperdal Consta 50 mg, Suspension zur i.m. Applikation - Set(s)
56092005 Janssen-Cilag AG
Risperdal Consta 50 mg, Suspension zur i.m. Applikation26.06.2002
Original26.06.2002
Risperidone (N05AX08)25.06.2007
WHO-DDD 
01.05.Set(s)
01.05.Injektionskit
B  
Yes 
IP 
175.35No
    
10 %217.90
7680560920050Synthetika
2569520 
Composition
Praeparatio sicca: risperidonum 50 mg, poly(lactidum-co-glycolidum). Solvens: carmellosum natricum, polysorbatum 20, dinatrii phosphas dihydricus, acidum citricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 2 ml, pro vase, in suspensione recenter reconstituta corresp. natrium 9.872 mg.
Packungsbestandteile
Injection suspension 
 
Active AgentDoseadditional_information
Risperidone50 mgPraeparatio sicca
BAG: Active AgentDose
Risperidone50 mg
 
Inactive agents
Poly(Lactidum-Co-Glycolidum)
 
Solvens
 
Injection suspension 
  
  
BAG: Active AgentDose
Risperidone50 mg
 
Inactive agents
Citric Acid
Carmellose Sodium
Disodium Phosphate Dihydrate
Sodium Chloride
Sodium Hydroxide
Polysorbatum 20
 
Source
Data was imported : 06.08.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home